Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Oncology
An Expert’s Perspective on What Daraxonrasib Means for the Future of Pancreatic Cancer Care
Phase 3 RASolute 302 data showed daraxonrasib doubled overall survival versus chemotherapy in previously treated metastatic pancreatic cancer. Mass General Brigham Cancer Institute is participating in the FDA-authorized expanded access program, with approximately 50 patients consented to date.
Featured In Urology
How a Neoadjuvant Microdevice Could Transform Treatment of Prostate Cancer
Mass General Brigham researchers are in the early stages of developing a 3mm implantable chip that delivers micro-doses of drugs directly into prostate tumors prior to planned radical prostatectomy. Analyzing tumor response eventually could help clinicians optimize drug selection for individual patients.
Featured In Neuroscience
Reimagining Neurologic Care Through Population Health Strategies
Two Mass General Brigham neurologists spent nearly a year examining how five esteemed academic health systems are using population health approaches to improve neurologic care. They are among the authors of a paper summarizing relevant case studies and lessons learned from their investigation.
Featured In OB/GYN
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer Improves Short-term Survival Regardless of Hospital Case Volume
For patients with advanced ovarian cancer, high use of neoadjuvant chemotherapy improves 90-day surgical mortality at hospitals of all case volumes, but that outcome and 5-year survival are best for patients treated at high-volume centers with high use of neoadjuvant chemotherapy.
Featured In Radiology
Emerging Treatment Offers Hope for Patients with Chronic Musculoskeletal Pain
Could a minimally invasive procedure ease chronic musculoskeletal pain? Yan Epelboym, MD, MPH, discusses the promise of trans-arterial embolization.
The Latest Oncology Advances
Mass General Brigham Launches Two Trials Aiming to Boost Resilience After Lymphoma Treatment
Two new Mass General Brigham-led clinical trials are testing a resilience program to help lymphoma survivors navigate post-treatment challenges. SMART3RP-Lymphoma incorporates strategies from mind body medicine, positive psychology, and cognitive behavioral treatment.
Treating Head and Neck Cancer Without Overtreating Patients
Researchers have developed an ultra-sensitive liquid biopsy that may help identify which patients with HPV-associated head and neck cancer can safely avoid unnecessary radiation or chemotherapy after surgery.
Contributing Physicians
Marcela V. Maus, MD, PhD
Director, Cellular Immunotherapy Program, Mass General Brigham Cancer Institute, Associate Professor of Medicine, Harvard Medical School
Advances Specialties
Cardiovascular
Study Reveals Brain-Heart Connection in Depression and Anxiety
Investigators at Mass General Brigham found that stress-related brain activity may explain the increased risk of heart disease with depression and anxiety.
Neuroscience
Study Details How Epstein-Barr Virus Reactivation May Lead to MS Relapses
Mass General Brigham investigators found Epstein-Barr virus lytic reactivation precedes multiple sclerosis (MS) relapses by roughly two to three months, interacting with MS risk genes to drive inflammatory B cell expansion and an immune cascade that can lead to individual flareups.
Orthopaedics
Advancing Minimally Invasive Surgical Techniques to Treat Hallux Rigidus
Mass General Brigham foot and ankle surgeon Christopher Miller, MD, is treating hallux rigidus via minimally invasive techniques for cheilectomy, fusion, first ray shortening osteotomy, and/or Moberg osteotomy. His goal is to offer each patient the right surgical option based on their unique goals and pathology.
May 9, 2025
Conference: Midlife Women's Health 2025: A Multidisciplinary Approach to Care
The Midlife Women's Health 2025 course is led by a multidisciplinary group of experts from Massachusetts General Hospital who will present on the evaluation and management of osteoporosis, gastrointestinal malignancy, stress, obesity, substance use disorder, anxiety, sexual dysfunction, breast cancer, and menopausal hormone therapy to assist clinicians in caring for their midlife patients.
Brain mechanisms of vagus nerve stimulation and stress reduction training for migraine
The study involves multiple visits over 6 months. You will complete an 8-week stress reduction treatment that includes a medical device worn in the ear and attend MRI and PET scans. You will also complete daily migraine diaries online.
Multimodal profiling of stress-induced immune reprogramming in cardiovascular participants
The purpose of this research study is to learn about the effects of stress on the brain and disease of the heart and blood vessels (cardiovascular disease or CVD).
